Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Alamar-ISO13485

More Like This

PR Newswire associated0

Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy

PR Newswire associated0

Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids

GlobeNewswire associated0

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

PR Newswire associated0

Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays

Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research

PR Newswire associated0

Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson's Research Through Development of Next Generation Biomarker Assays

Alamar Biosciences logo (Graphic: Business Wire)

ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

PR Newswire associated0

Alamar Biosciences and ALZpath, Inc. Announce Strategic Supply Agreement for pTau217 Antibody to Advance Alzheimer's Disease Research